Business Wire

Weber Inc . Transforms Outdoor Cooking With Innovative 2022 Product Portfolio

Share

Weber Inc. (NYSE:WEBR), the global leader in outdoor cooking innovation, technology, and products, today unveiled the first three new products in its 2022 grilling portfolio. Designed to fuse the best in smart technology, high-quality materials, performance engineering, and craftsmanship, the 2022 GENESIS Smart Gas Grill, 2022 SMOKEFIRE Wood Fired Pellet Grill, STEALTH Edition, and all-new WEBER CRAFTED Outdoor Kitchen Collection take cooking outdoors to new levels of food discovery and exploration.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220118005538/en/

To view this piece of content from mms.businesswire.com, please give your consent at the top of this page.

Weber Genesis Smart Gas Grill, Model EPX-335. (Photo: Business Wire)

“Our product lineup for the upcoming barbecue season pushes the boundaries of the types of cooking that can be done outdoors, including bringing popular methods like flat top cooking and baking right to a WEBER grill,” said Jennifer Bonuso, Senior Vice President and General Manager, Global Product Management of Weber. “These new products are shaped by insights from grilling enthusiasts around the world, who crave to create more when they cook outside. We answered that desire by bringing together our best smart technology, new features, and a unique grillware collection.”

ABOUT THE NEW WEBER CRAFTED OUTDOOR KITCHEN COLLECTION

The WEBER CRAFTED Outdoor Kitchen Collection is a line of exclusive, high-quality, interchangeable grillware that enables a variety of different cooking methods. Outdoor cooks can use traditional grill grates or switch in a flat-top surface to open up a world of new foods at the grill, like eggs, pancakes, smashed burgers, and more. Exchange the grates for a baking stone for pizzas, crispy flatbreads, and cookies, or use rotisserie skewers for kabobs and roasted chicken. The Collection transforms the grill into a versatile, complete outdoor kitchen.

The WEBER CRAFTED line features six cooking pieces -- each providing a large cooking surface -- that facilitate steaming, baking, roasting, searing, or flat top cooking right at the grill. The complete grillware Collection consists of a Dual-Sided Sear Grate, Flat Top, Glazed Baking Stone, Roasting Basket, Wok & Steamer, and Rotisserie Skewer pieces. Additionally, it includes specially designed grates and an insert that allows the grillware pieces to be easily changed out on a WEBER gas, charcoal, or pellet grill.

Each WEBER CRAFTED item is sold separately.

ABOUT THE NEW WEBER GENESIS SMART GAS GRILL

The 2022 GENESIS Smart Gas Grill, Weber’s most advanced gas grill in 15 years, creates the ultimate culinary experience for grilling enthusiasts.

Built with high-quality materials, ingenuity, and the craftsmanship Weber is known for, the 2022 GENESIS grill is feature-packed to bring a complete outdoor kitchen experience to any outside space, including:

  • WEBER CRAFTED Outdoor Kitchen Collection-ready with cooking gratesspecially designed to accommodate the WEBER CRAFTED grate insert and grillware pieces (sold separately) and unlock a wide range of cooking options at the grill.
  • Integrated WEBER CONNECT smart grilling technology creates perfectly grilled food through real-time food temperature alerts, reminders, and flip and serve notifications at the grill or on the phone. With the WEBER CONNECT App, outdoor cooks can stay connected to their grill while taking care of guests, watching the game, or enjoying a drink.
  • Proprietary PUREBLU high heat burnersaredesigned toproduce the most efficient, even flame for consistent, precise heat and reliable ignition.
  • Extra-large SEAR ZONE allows outdoor cooks to sear multiple food items simultaneously.
  • Extra-large Prep and Serve Table accommodates more trays and dishes than previous GENESIS models.
  • NIGHTVISION motion-sensor, under-the-lid LED lights illuminate the entire grilling surface - from the side table to the grates. This patent-pending lighting system is ideal for early morning, dusk, and nighttime outdoor cooking.
  • Expandable, Top Cooking Grate increases the overall available grilling space of the 2022 GENESIS grill, providing extra room to cook appetizers, sides, or main course dishes, all at the same time.

The 2022 GENESIS gas grill line includes several different three and four-burner models. In addition, models are available in porcelain-enamel or stainless steel finishes.

ABOUT THE NEW SMOKEFIRE WOOD PELLET GRILL, STEALTH EDITION

The 2022 SMOKEFIRE Wood Fired Pellet Grill, STEALTH Edition, brings a sleek, distinctive black-on-black aesthetic to Weber’s all-in-one SMOKEFIRE pellet grilling experience, which centers on exceptional wood fired flavor through both high heat searing and low and slow smoking,

The 2022 SMOKEFIRE Grill, STEALTH Edition, includes:

  • All-black exterior styling.
  • WEBER CRAFTED Outdoor Kitchen Collection - ready to open up the types of meals that can be made on a pellet grill, adding the ability to roast, steam, and even stir-fry.
  • WEBER CONNECT smart grilling technology
  • Built-in grill lighting illuminates the cooking grate for those extended evening or early morning cooks.
  • Atop cooking grate provides a large, second level of grilling capacity.
  • Porcelain-enamel construction retains heat, even in cooler temperatures, and helps prevent rust and cracking.

The 2022 SMOKEFIRE Wood Fire Pellet Grill, STEALTH Edition series includes two models. Available models will vary by geographic region.

And to help inspire mealtime, Weber recently updated its popular WEBER CONNECT App with recipes, recipe collections, and additional cook programs that feature dishes and meal ideas that outdoor cooks can easily create with these new products. Weber owners can explore recipes for simple fare such as Balsamic Glazed Pork Chops with Peach Salsa and Grilled Carrots with Nutmeg Butter, to more sophisticated dishes such as Lemon-Ginger Tofu Steaks with Carrot and Cashew Salad or Chargrilled Oysters with Creole Remoulade Sauce and Grill Corn on the Cob with Basil Parmesan Butter.

The full 2022 GENESIS Gas Grill line and WEBER CRAFTED Outdoor Kitchen Collection will be available in the Americas and Europe leading up to the Spring barbecuing season from Weber websites and retail partners worldwide. In North America, consumers can purchase select models of the 2022 Genesis gas grill line and WEBER CRAFTED Collection online and in-store now. In addition, the 2022 SMOKEFIRE Wood Fired Pellet Grill, STEALTH Edition, will be available for purchase this Spring.

ABOUT WEBER INC.

Weber Inc. headquartered in Palatine, Ill., is the world’s leading barbecue brand. The Company’s founder George Stephen, Sr., established the outdoor cooking category when he invented the original kettle charcoal grill nearly 70 years ago. Weber offers a comprehensive, innovative product portfolio, including charcoal, gas, pellet and electric grills, smokers, and accessories designed to help outdoor cooking enthusiasts discover what’s possible. In 2021, the Company acquired June Life Inc., a smart appliance and technology company, to accelerate the development of its Weber Connect technology and digital products. In addition, Weber recently launched 1952 Ventures, a subsidiary designed to accelerate new growth platforms and brand extensions for the Company in the areas of product, technologies, and partnerships. Weber offers its barbecue grills and accessories, services, and experiences to a passionate community of millions across 78 countries.

WEBER®, GENESIS®, SMOKEFIRE®, and WEBER CONNECT® are U.S. registered trademarks; STEALTH; NIGHTVISION, PUREBLUE, and SEAR ZONE are trademarks; all owned by Weber-Stephen Products LLC.

FUTURE STATEMENTS

This press release contains various “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995, which represent Weber’s expectations or beliefs concerning future events. In some cases, you can identify these statements by forward-looking words such as “may,” “might,” “will,” “should,” “expects,” “plans,” “anticipates,” “believes,” “estimates,” “predicts,” “potential” or “continue,” the negative of these terms and other comparable terminology. There are important factors that could cause our actual results, level of activity, performance or achievements to differ materially from the results, level of activity, performance or achievements expressed or implied by the forward-looking statements, including those factors listed in the Company's filings with the Securities and Exchange Commission, including the most recent Annual Report on Form 10-K, Quarterly Reports on Form 10-Q, and Current Reports on Form 8-K.

Our future results could be affected by a variety of other factors, including uncertainty of the magnitude, duration, geographic reach, impact on the global economy and current and potential travel restrictions of the COVID-19 outbreak, the current, and uncertain future, impact of the COVID-19 outbreak on our business, growth, reputation, prospects, financial condition, operating results (including components of our financial results), and cash flows and liquidity, risks relating to any unforeseen changes to or effects on liabilities, future capital expenditures, revenues, expenses, earnings, synergies, indebtedness, financial condition, losses and future prospects, the ability to realize the anticipated benefits and synergies from business acquisitions in the amounts and at the times expected, the impact of competitive conditions, the effectiveness of pricing, advertising, and promotional programs; the success of innovation, renovation and new product introductions; the recoverability of the carrying value of goodwill and other intangibles, the success of productivity improvements and business transitions, commodity and energy prices, transportation costs, labor costs, disruptions or inefficiencies in supply chain, the availability of and interest rates on short-term and long-term financing, the levels of spending on systems initiatives, properties, business opportunities, integration of acquired businesses, and other general and administrative costs, changes in consumer behavior and preferences, the effect of U.S. and foreign economic conditions on items such as interest rates, statutory tax rates, currency conversion and availability, legal and regulatory factors including the impact of any product recalls; and business disruption or other losses from war, pandemic, terrorist acts or political unrest.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

Kristina Peterson-Lohman
media@weber.com

Brian Eichenlaub
investors@weber.com

About Business Wire

Business Wire
Business Wire
24 Martin Lane
EC4R 0DR London

+44 20 7626 1982http://www.businesswire.co.uk

(c) 2018 Business Wire, Inc., All rights reserved.

Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Takeda and Seagen to Highlight ADCETRIS ® Combination Data Showing Statistically Significant Improvement in Overall Survival (OS) for Patients with Advanced Hodgkin Lymphoma26.5.2022 23:25:00 CEST | Press release

Takeda Pharmaceutical Company Limited (TSE:4502) and Seagen Inc., (NASDAQ:SGEN) today announced that overall survival (OS) data from the Phase 3 ECHELON-1 clinical trial of an ADCETRIS® (brentuximab vedotin) plus chemotherapy combination will be presented in an oral session at the 59th American Society of Clinical Oncology (ASCO) Annual Meeting on Friday, June 3, 2022, 1:00-4:00 PM CT, and at the 27th European Hematology Association (EHA) Annual Meeting on Friday, June 10, 2022, 11:30 – 12:45 CEST. “The longer-term follow-up data from the ECHELON-1 trial have significant clinical importance, as this trial represents one of only two frontline randomized studies in advanced stage Hodgkin lymphoma that shows an overall survival advantage for the experimental arm,” said Stephen Ansell, M.D., Ph.D., Mayo Clinic, and ECHELON-1 study investigator. “These results clearly show that the addition of brentuximab vedotin to chemotherapy improves the long-term outcome of patients and the combination

Ipsen: ASCO 2022: New Cabometyx ® Data Show Encouraging Results in Monotherapy and in Combination Across Different Tumor Types Including Metastatic Non-Small Cell Lung Cancer26.5.2022 23:00:00 CEST | Press release

Regulatory News: Ipsen (Euronext: IPN; ADR: IPSEY) today announced encouraging data to be presented for the multi-targeted tyrosine kinase inhibitor (TKI), Cabometyx® (cabozantinib), across a range of cancer types at this year’s American Society of Clinical Oncology Annual Meeting (ASCO 2022) to be held on 3-7 June. Data presentations will include findings in metastatic non-small cell lung cancer (NSCLC), as well as established indications of advanced renal cell carcinoma and radioactive iodine-refractory differentiated thyroid cancer (RAI-R DTC). These data show that the therapeutic potential of Cabometyx as a key treatment option in a broad range of tumors is continuing to be realized. Updated outcomes from the multicenter Phase Ib COSMIC-021 trial evaluating the combination of Cabometyx plus atezolizumab in an expanded patient population in metastatic NSCLC demonstrate encouraging clinical activity with manageable toxicity in people previously treated with an immune checkpoint inhib

New Better Dispensing Videos from Nordson EFD Explain Jetting Technology and How to Choose the Right Solution26.5.2022 19:00:00 CEST | Press release

Nordson EFD, a Nordson company (NASDAQ: NDSN) and leading precision fluid dispensing systems manufacturer, introduces a new Better Dispensing™ How-To Video series. These three highly educational videos presented by EFD application specialist, Tom Muccino, provide best practices for choosing between contact dispensing and non-contact (jet) dispensing, and how to select the best jetting valve for a manufacturing application. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220510006079/en/ xQR41 Series MicroDot™ needle valve (left) and PICO Pµlse XP jet valve (right). (Photo: Business Wire) “One of the main differences is that with jetting, your valve never touches the surface of the part. Instead, your fluid “flies” or “jets” out of the valve, which is above the part,” Muccino explains in the first video. “This makes jetting perfect for fragile or complex parts.” Nordson EFD provides a wide range of contact and non-contact (jet

Medisca Drives Worldwide Access to Thyroid through Distribution License with SUANFARMA26.5.2022 18:17:00 CEST | Press release

On March 16, 2022, Medisca, a global supplier of pharmaceutical ingredients and equipment, entered into an exclusive agreement with SUANFARMA, a European-based manufacturer and distributor of pharmaceutical ingredients, for the global supply and distribution of Thyroid Powder, USP, by leveraging its exclusive partnership with pharmaceutical manufacturer, Sichuan Deebio Pharmaceutical Co., Ltd (Deebio). “Partnering with Deebio in June 2021 was a huge milestone for the pharmaceutical compounding industry as it allowed us to secure and stabilize the supply of high quality Thyroid Powder for the US market,” said Panagiota Danopoulos, Senior Vice President of Global Strategy & Innovation at Medisca. “After going to market, we immediately realized that the demand for Thyroid Powder extended outside of our usual distribution channels to compounding pharmacies,” continued Danopoulos. “And we had the capacity to upscale supply to make this critical ingredient accessible to various markets, chan

Merck to Present Latest Research From Oncology Portfolio at ASCO 202226.5.2022 18:00:00 CEST | Press release

Merck, a leading science and technology company, today announced the latest research representing the Company’s innovative oncology portfolio has been accepted for presentation at this year’s American Society of Clinical Oncology (ASCO) Annual Meeting, June 3-7, 2022. Data encompass Company-sponsored, investigator-sponsored, and external collaboration studies. Abstracts to be shared at the meeting include data for the Company’s licensed medicines BAVENCIO® (avelumab), TEPMETKO® (tepotinib) and ERBITUX® (cetuximab), and its oncology pipeline. The presentations span key tumor types including advanced urothelial carcinoma (UC), advanced renal cell carcinoma (RCC), metastatic non-small cell lung cancer (NSCLC), metastatic colorectal cancer (CRC), and head and neck cancer (SCCHN). “We look forward to coming together with the scientific community at ASCO 2022, where we will share the latest data from our portfolio, which demonstrate our determination to make a real difference in the lives of